iNAP will be present at the highly anticipated #SLEEP2023
iNAP is at SLEEP 2023, the premier event for sleep professionals and researchers.
Join us at Booth #206 ！
top of page
Sleep well.
Wherever you are.
A Novel Treatment for Obstructive Sleep Apnea Patients
Somnics develops in innovative technologies for the treatment of Obstructive Sleep Apnea.
Without masks and surgery, our iNAP® Sleep Therapy System provides a comfortable and discreet treatment for patients.
iNAP Features
Natural Breathing
iNAP allows you to breathe through the nose naturally without blowing air into the body while sleeping.
Compact and Travel-friendly
iNAP is incredibly light, small and compact. It fits in one hand and is therefore very travel-friendly.
Operation Without a Mask
iNAP works without having to wear cumbersome facial masks, belts or large hoses. iNAP is both easy-fitting and non-intrusive.
Discreet and Quiet
iNAP console is silent when negative pressure is reached and maintained, allowing you to sleep peacefully.
Superior Wearing Comfort
iNAP has a soft and flexible oral interface with thermal-memory material and one-size-fits-all design.
Portable and Rechargeable
iNAP is battery powered and ultra-portable for any situation, such as traveling by flight, camping, and mountaineering.
How it works
Patent Information
iNAP sleep therapy system and/or the use thereof in a method may be covered by one or more U.S. and/or foreign patents, including: US 7,918,222, US 8,567,406, US 8,616,208, US 9,138,342, US 9,387,117, US 9,339,620, US 10,080,855, US 10,149,782, US 10,149,783, US 10,159,595, US 10,166,140, US 8,122,889, US 8,656,922, US 8,667,970, US 9,241,825, US 9,655,768, US 8,505,540, US 9,610,190, US 8,074,656, US 8,122,890, US 8,701,672, US 8,387,620, US 9,387,118, US 9,387,119, US 10,117,773, US 8,402,973, US 8,573,223, US 8,979,823, US 9,549,795, US 9,101,495, US 9,375,541, US 9,763,759, US 9,483,792, US 15,376,368, EP 1862152, EP 2301490, EP 2347739, EP 2353555, EP 2868298, EP 2943170, EP 3095421, EP 2881090, EP 2209433, EP 2939634, EP 2605722, EP 0029004490001 RCD, EP 0029004490002 RCD, DE 2015121115024300, JP 5399534, JP 5727574, JP 5651488, JP 6002798, JP 6242914, JP 6346997, JP 6357573, JP 5404642, JP 5952817, JP 59944828, KR 10-1636436-0000, KR 10-1661639-0000, AU 2014205191, AU 2015399751, VN 3-2016-00928, VN 3-2016-00929, ID A00201601834, ID A00201601835, SG 30201602584Y, SG 30201602585X, TH 1602002134, TH 1602002135, IN 283925, IN 283926, CN 100506190, CN 102028574, CN 102133141, CN 102144946, CN 103989550, CN 103976814, CN 104000680, CN 104519841, CN 104540480, CN 104427958, CN 106170272, CN 205494125, CN 101917924, CN 103687568, CN 103140192, CN 103717181, and CN 201721828424.2 Other U.S. and foreign patent applications are pending. 睡眠呼吸中止
bottom of page